STEREOTAXIS INC STXS 深 滬
等待開盤 10-25 09:30:00 美东时间
3.09
-0.010
-0.32%
華盛通- 最 高3.15
- 今 開3.13
- 成交量 46.71万股
- 最 低 3.07
- 昨 收 3.10
- 總市值 2.81亿
- 52周最高 3.59
- 市盈率 靜 --
- 換手率 0.51%
- 52周最低 1.54
- 委 比 66.67%
- 總股本 9107.15万
- 歷史最高 10.30
- 量 比 1.34
- 振 幅 2.58%
- 歷史最低 1.33
- 每 手 1
- 風險率 0.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs
Stereotaxis, a leader in surgical robotics, has secured CE Mark in Europe and filed a 510(k) with the FDA for its Synchrony system. Designed to modernize interventional cath labs, Synchrony features a 55” 4K display, seamless integration of lab systems, and low-latency crystal-clear visualization. Its cloud-based SynX app offers secure remote connectivity and collaboration. Experts highlight Synchrony’s advanced architecture, improved workflow, a...
10-15 11:32
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
Stereotaxis and CardioFocus have entered a collaboration to advance robotic Pulsed Field Ablation (PFA) technology for treating cardiac arrhythmias. Combining CardioFocus' Centauri PFA System with Stereotaxis' MAGiC robotic catheter, the partnership aims to enhance precision, efficiency, and safety in cardiac ablation procedures. Preclinical studies have shown promising results in lesion delivery. The collaboration plans to move to clinical trial...
10-13 11:34
Stereotaxis' Genesis Robotic Magnetic Navigation System Used In First Procedures By Physicians At Erasmus University MC In Netherlands
Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced successful first procedures by physicians at Erasmus University Medical Center
09-22 19:59
Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System
Stereotaxis announced successful first procedures at Erasmus University Medical Center in Rotterdam using the advancedGenesis Robotic Magnetic Navigation System. Dr. Sing-Chien Yap highlighted the system's speed, responsiveness, and synergy with the MAGiC Catheter for treating arrhythmias, including complex cases. Erasmus MC has performed over 4,500 robotic procedures, making it a global leader in robotic magnetic navigation for heart rhythm mana...
09-22 11:56
两大巨头联手下场，手术机器人迎来新爆点
手术机器人领域又迎重磅选手加入！ 近日，两大医疗器械巨头西门子医疗和史赛克宣布，将共同开发神经血管介入手术机器人，能够执行全面的择期和紧急神经血管介入手术，包括...
09-19 08:04
First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter
Stereotaxis announced the successful completion of the world’s first procedures using its MAGiC Sweep™, a robotically-navigated high-density electrophysiology mapping catheter. The procedures were performed by Dr. Raffaele Corbisiero and Dr. Pedram Kazemian at Deborah Heart and Lung Center. The catheter demonstrated stable contact, clear signals, and no ectopy in the ventricle, marking a significant advancement in robotic electrophysiology. MAGiC...
09-02 12:08
Stereotaxis to Present at Upcoming Investor Conferences
<p align="justify">Stereotaxis, a leader in surgical robotics, announced that CEO David Fischel will present at two investor conferences in NYC. On September 10, 2025, he will speak at the H.C. Wainwright Global Investment Conference and be available for one-on-one meetings. The next day, he will attend the Lake Street Capital Best Ideas Growth Conference. Fischel expressed excitement about sharing the company’s technological advancements and gro...
09-02 11:51
Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025
Stereotaxis will showcase its surgical robotics technology at HRX 2025, a digital health conference in Atlanta, Sept 4-6. CEO David Fischel will discuss robot-enhanced electrophysiology, followed by a panel exploring advanced ablation techniques, VR, AI, and automation in heart rhythm care. The company aims to shape an innovative future for electrophysiology.
08-28 11:47
Stereotaxis Earnings Call Highlights Growth and Challenges
Stereotaxis (($STXS)) has held its Q2 earnings call. Read on for the main highl...
08-12 08:53
Stereotaxis Q2 EPS $(0.05) Beats $(0.07) Estimate, Sales $8.798M Beat $7.750M Estimate
Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 30.56 percent. This is a 28.57 percent increase over losses of $(0.07) per share from the
08-08 04:03
